The Multidisciplinary Pituitary & Skull Base Tumor Center at Memorial Sloan Kettering is involved in a number of clinical trials investigating new medical therapies for patients with Cushing’s disease and acromegaly. These clinical trials give Cushing’s and acromegaly patients access to emerging medications and therapies.

Dr. Geer also follows a large cohort of patients with Cushing’s disease prospectively over time in an effort to understand long-term outcomes for these patients after treatment. She has conducted studies on the effects of Cushing’s on body composition, appetite, and inflammation, and is continuing to investigate changes in adipose tissue on people with Cushing’s before and after treatment. She is also collecting data on mood and quality of life for Cushing’s patients long term. Her prospective Cushing’s cohort is a unique resource for enhancing our understanding of this rare disease, with the aim to improve treatment and outcomes for these patients.